Sort
166,118 grants matching “stem cells”
Endocytic Mechanisms in the Hereditary Spastic Paraplegias
$1,476,236Craig Blackstone · National Institute Of Neurological Disorders And Stroke · ZIA · FY2017 · NS
Bio-Organic Biomedical Mass Spectrometry Resource
$1,476,120Alma L Burlingame · University Of California, San Francisco · P41 · FY2008 · RR
Annotated lineage trees of murine development
$1,476,000Aaron H McKenna · Dartmouth College · DP2 · FY2022 · GM
Engineering enhanced erythropoiesis for red blood cell disorders
$1,476,000Michael Kyle Cromer · University Of California, San Francisco · DP2 · FY2025 · HL
Elucidating the molecular mechanisms of sensory regeneration
$1,476,000John Ngai · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
Targeting tau for the development of novel Alzheimer's disease therapeutics
$1,475,961Glenn Larsen · Aquinnah Pharmaceuticals, Inc. · R44 · FY2020 · AG
Studies on Monoclonal Gammopathies
$1,475,669Diane F Jelinek · Mayo Clinic Rochester · P01 · FY2009 · CA
The Mutant Mouse Resource and Research Center at the University of Missouri - Resource
$1,475,449Craig L Franklin · University Of Missouri-Columbia · U42 · FY2020 · OD
Discovery of genes required for expression or activity of fusion oncogenes
$1,475,356Natasha Caplen · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Collaborative Research: Connected Biology: three-dimensional learning from molecules to populations
$1,475,187Frieda Reichsman · Concord Consortium · · FY2016 · EDU
alpha-Synuclein and LRRK2 in the Pathogenesis of Parkinson's Disease
$1,475,093Jie Shen · Brigham And Women'S Hospital · P50 · FY2015 · NS
Immunobiology and immunotherapy of leukemia
$1,475,058Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Characterization and improvement of graft versus leukemia effects
$1,475,058Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
IGF::OT::IGF: SBIR Phase II, Topic 326: Development of Novel Therapeutic Agents that Target Cancer
$1,475,002Rajappa Kenchappa · Transgenex Nanobiotech, Inc. · N44 · FY2017 · CA
Gene and Cell Therapy of Duchenne Muscular Dystrophy
$1,474,970University Of Pittsburgh At Pittsburgh · U54 · FY2004 · AR
Epigenetic Regulation of Embryonic and Hematopoietic Stem Cells
$1,474,568Keji Zhao · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Epigenetic Regulation of T cell differentiation
$1,474,568Keji Zhao · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Characterization of epidermal stem cells: biology, carcinogenesis, and function
$1,474,513Raymond W Tennant · Environmental Health Sciences · Z01 · FY2007 · ES
Developmental Neurotoxicity Health Effects Innovation Research Program
$1,474,403Christopher Anthony McPherson · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
Mechanisms of Normal Tissue Toxicity From Irradiation
$1,474,166Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery
$1,474,145Martin R. Pollak · Beth Israel Deaconess Medical Center · RC2 · FY2022 · DK
Interventional approaches for restoring vision
$1,474,118Anand Swaroop · National Eye Institute · ZIA · FY2014 · EY
Cross-Species and Evolutionary Biology
$1,474,040Ryan Tewhey · Translational Genomics Research Inst · U19 · FY2024 · AG
Development Of Theoretical Methods For Studying Biological Macromolecules
$1,473,710Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
PLURIPOTENT STEM CELL-DERIVED CORNEAL ENDOTHELIAL CELLS FOR TREATMENT OF COMBAT LASER-INDUCED CORNEAL EDEMA AND VISION RESTORATION
$1,473,430The Johns Hopkins University · · FY2024 · Defense Health Agency